These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 2787958)

  • 81. Patient reported receipt of medication instructions for warfarin is associated with reduced risk of serious bleeding events.
    Metlay JP; Hennessy S; Localio AR; Han X; Yang W; Cohen A; Leonard CE; Haynes K; Kimmel SE; Feldman HI; Strom BL
    J Gen Intern Med; 2008 Oct; 23(10):1589-94. PubMed ID: 18618191
    [TBL] [Abstract][Full Text] [Related]  

  • 82. A bleeding risk index for estimating the probability of major bleeding in hospitalized patients starting anticoagulant therapy.
    Landefeld CS; McGuire E; Rosenblatt MW
    Am J Med; 1990 Nov; 89(5):569-78. PubMed ID: 2239976
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Prospective evaluation of an index for predicting the risk of major bleeding in outpatients treated with warfarin.
    Beyth RJ; Quinn LM; Landefeld CS
    Am J Med; 1998 Aug; 105(2):91-9. PubMed ID: 9727814
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Anticoagulant-related bleeding: clinical epidemiology, prediction, and prevention.
    Landefeld CS; Beyth RJ
    Am J Med; 1993 Sep; 95(3):315-28. PubMed ID: 8368229
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Risk factors for complications of chronic anticoagulation. A multicenter study. Warfarin Optimized Outpatient Follow-up Study Group.
    Fihn SD; McDonell M; Martin D; Henikoff J; Vermes D; Kent D; White RH
    Ann Intern Med; 1993 Apr; 118(7):511-20. PubMed ID: 8280198
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Effectiveness of screening for atrial fibrillation and its determinants. A meta-analysis.
    Petryszyn P; Niewinski P; Staniak A; Piotrowski P; Well A; Well M; Jeskowiak I; Lip G; Ponikowski P
    PLoS One; 2019; 14(3):e0213198. PubMed ID: 30893323
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Oral anticoagulants for prevention of stroke in atrial fibrillation: systematic review, network meta-analysis, and cost effectiveness analysis.
    López-López JA; Sterne JAC; Thom HHZ; Higgins JPT; Hingorani AD; Okoli GN; Davies PA; Bodalia PN; Bryden PA; Welton NJ; Hollingworth W; Caldwell DM; Savović J; Dias S; Salisbury C; Eaton D; Stephens-Boal A; Sofat R
    BMJ; 2017 Nov; 359():j5058. PubMed ID: 29183961
    [No Abstract]   [Full Text] [Related]  

  • 88. Screening strategies for atrial fibrillation: a systematic review and cost-effectiveness analysis.
    Welton NJ; McAleenan A; Thom HH; Davies P; Hollingworth W; Higgins JP; Okoli G; Sterne JA; Feder G; Eaton D; Hingorani A; Fawsitt C; Lobban T; Bryden P; Richards A; Sofat R
    Health Technol Assess; 2017 May; 21(29):1-236. PubMed ID: 28629510
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Phase angle variability on bleeding risks in hemodialysis patients.
    Ohta M; Kan T; Yoshida Y; Sato H; Hoshino T; Sato T; Hoshino Y
    Clin Exp Nephrol; 2024 Oct; ():. PubMed ID: 39406994
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Anticoagulant-related bleeding as a sign of underlying tumoural lesions in patients with atrial fibrillation: a nationwide cohort study.
    Proesmans K; Grymonprez M; Rottey S; Lahousse L
    Eur Heart J Open; 2024 Sep; 4(5):oeae081. PubMed ID: 39399206
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Anti-coagulants-induced intracranial hemorrhage managed with decompressive craniectomy: a case report of lesson learned.
    Ghimire S; Shrestha S; Shrestha D; Maharjan A; Jaiswal B; Chaudhary P; Sherpa S
    Ann Med Surg (Lond); 2024 May; 86(5):3036-3041. PubMed ID: 38694382
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Thrombin Generation Is Associated with Venous Thromboembolism Recurrence, but Not with Major Bleeding and Death in the Elderly: A Prospective Multicenter Cohort Study.
    Vrotniakaite-Bajerciene K; Rütsche S; Calzavarini S; Quarroz C; Stalder O; Mean M; Righini M; Staub D; Beer JH; Frauchiger B; Osterwalder J; Kucher N; Matter CM; Husmann M; Banyai M; Aschwanden M; Mazzolai L; Hugli O; Rodondi N; Aujesky D; Angelillo-Scherrer A
    J Clin Med; 2023 Sep; 12(18):. PubMed ID: 37762997
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Stroke-Specific Predictors of Major Bleeding in Anticoagulated Patients With Stroke and Atrial Fibrillation: A Nationwide Multicenter Registry-Based Study.
    Chung D; Song TJ; Kim BJ; Heo SH; Jung JM; Oh K; Kim CK; Yu S; Park KY; Kim JM; Park JH; Park MS; Kim JT; Hwang YH; Kim YJ; Chung JW; Bang OY; Kim GM; Seo WK; Choi JC
    J Clin Neurol; 2023 Sep; 19(5):429-437. PubMed ID: 37455504
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Mansoor's Self-Report Tool for Cardiovascular Risk Assessment predicts adverse in-hospital events in patients with pulmonary embolism.
    Keller K; Schmitt VH; Ostad MA; Münzel T; Hobohm L; Espinola-Klein C
    Clin Respir J; 2023 Feb; 17(2):80-89. PubMed ID: 36544042
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Tele-pharmacy Anticoagulation Clinic During COVID-19 Pandemic: Patient Outcomes.
    Al Ammari M; AlThiab K; AlJohani M; Sultana K; Maklhafi N; AlOnazi H; Maringa A
    Front Pharmacol; 2021; 12():652482. PubMed ID: 34566632
    [No Abstract]   [Full Text] [Related]  

  • 96. Validation of the IMPROVE bleeding risk score in Chinese medical patients during hospitalization: Findings from the dissolve-2 study.
    Zhang Z; Zhai Z; Li W; Qin X; Qu J; Shi Y; Xu R; Xu Y; Wang C;
    Lancet Reg Health West Pac; 2020 Nov; 4():100054. PubMed ID: 34327391
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Anticoagulation versus placebo for heart failure in sinus rhythm.
    Shantsila E; Kozieł M; Lip GY
    Cochrane Database Syst Rev; 2021 May; 5(5):CD003336. PubMed ID: 34002371
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Provoked versus unprovoked venous thromboembolism: Findings from GARFIELD-VTE.
    Ageno W; Farjat A; Haas S; Weitz JI; Goldhaber SZ; Turpie AGG; Goto S; Angchaisuksiri P; Dalsgaard Nielsen J; Kayani G; Schellong S; Bounameaux H; Mantovani LG; Prandoni P; Kakkar AK
    Res Pract Thromb Haemost; 2021 Feb; 5(2):326-341. PubMed ID: 33733032
    [TBL] [Abstract][Full Text] [Related]  

  • 99. A Study of Proton Pump Inhibitors and Other Risk Factors in Warfarin-Associated Gastrointestinal Bleeding.
    Tang J; Sharma U; Desai S; Molnar J; Perlmuter L; Feller A; Shah P
    Cureus; 2021 Jan; 13(1):e12624. PubMed ID: 33585113
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Stroke and Bleeding Risk Assessments in Patients With Atrial Fibrillation: Concepts and Controversies.
    Ding WY; Harrison S; Gupta D; Lip GYH; Lane DA
    Front Med (Lausanne); 2020; 7():54. PubMed ID: 32154260
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.